CSIMarket Company Name, Ticker, Customers, else..
 
Zynerba Pharmaceuticals Inc   (NASDAQ: ZYNE)
 

ZYNE's Market share relative to its competitors, as of Q2 2023

As of Q2 2023 (Revenue in Millions of $)

Date modified: 2026-09-10T18:18:47+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q2 2023		 MARKET SHARE
12 Months
Q2 2023		 MARKET SHARE
MRQ
Q2 2023		 MARKET SHARE
A Quarter Before
Q1 2023
Zynerba Pharmaceuticals Inc 0.00 0.00% 0.00 % 0.00 %
Vertex Pharmaceuticals Inc 12,218.00 39.85% 40.39% 37.90%
Incyte Corporation 5,361.02 17.49% 15.42% 19.12%
Horizon Therapeutics Public Limited Company 3,643.45 11.88% 11.44% 10.56%
Biomarin Pharmaceutical Inc 3,242.32 10.57% 11.99% 9.72%
Sarepta Therapeutics Inc 2,184.18 7.12% 4.86% 9.27%
66 more competitors available

Sign in to see all competitors for Zynerba Pharmaceuticals Inc .

Sign In Create Free Account



ZYNE's Market share relative to its competitors, as of Q2 2023 within the Major Pharmaceutical Preparations Industry
As of Q2 2023



COMPANY NAME MARKET SHARE
12 Months Ending
Q2 2023		 MARKET SHARE
12 Months Ending
Q1 2023		 MARKET SHARE
MRQ
Q2 2023		 MARKET SHARE

Q1 2023
Zynerba Pharmaceuticals Inc 0.00% 0.00% 0.00 % 0.00 %
Vertex Pharmaceuticals Inc 48.32% 48.95% 47.78% 46.89%
Horizon Therapeutics Public Limited Company 14.41% 14.59% 13.53% 13.06%
Biomarin Pharmaceutical Inc 12.82% 13.14% 14.18% 12.03%
Sarepta Therapeutics Inc 8.64% 8.97% 5.75% 11.47%
Insmed Inc 2.92% 2.13% 6.10% 4.49%
61 more companies available

Sign in to see all industry competitors for Zynerba Pharmaceuticals Inc .

Sign In Create Free Account



ZYNE's Market share relative to its competitors, as of Q2 2023 within the Healthcare Sector
As of Q2 2023



COMPANY NAME MARKET SHARE
12 Months Ending
Q2 2023		 MARKET SHARE
12 Months Ending
Q1 2023		 MARKET SHARE
MRQ
Q2 2023		 MARKET SHARE

Q1 2023
Zynerba Pharmaceuticals Inc 0.00% 0.00% 0.00 % 0.00 %
Vertex Pharmaceuticals Inc 39.87% 40.47% 40.41% 37.92%
Incyte Corporation 17.49% 17.34% 15.42% 19.13%
Horizon Therapeutics Public Limited Company 11.89% 12.06% 11.44% 10.56%
Biomarin Pharmaceutical Inc 10.58% 10.86% 12.00% 9.73%
Sarepta Therapeutics Inc 7.13% 7.41% 4.86% 9.28%
63 more companies available

Sign in to see all sector competitors for Zynerba Pharmaceuticals Inc .

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Zynerba Pharmaceuticals Inc's market divisions, geographic dispersion, segments, products, and services, visit Zynerba Pharmaceuticals Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.